Blue Matter is a firm that’s not afraid to tell it like it is. Built into its purpose statement is a staunch aversion to the “rigid processes,” “bloated deliverables,” and “mediocre answers” that stymy original thinking. Established by seasoned consultants, Blue Matter fosters innovation and creativity to bring meaningful impact to the life sciences industry. Those values seem to pay off in spades, considering this nimble boutique has expanded rapidly since it was founded in 2012—with European offices in London, Zurich, and Berlin.<...
Major Departments/Practice Areas
Major Office Locations
CEO & Managing Partner
With offices across five countries, Blue Matter is a boutique firm that has been doing some serious growing of late. With that growth has come challenges—particularly around maintaining the people-centric culture that is at the heart of its early success. While that is not unusual for firms that are growing—and tends to be less of an issue for newcomers than those who have been with the firm for a while—it is something that is worth considering when talking to current employees about their experiences at the firm.
On a day-to-day basis, the company appears to offer a terrific work-life balance to the majority of its employees, along with opportunities to do high-profile pharma consulting projects. As a result, career development and growt...
Founded in 2012, Blue Matter is a specialized management consulting firm serving the life sciences industry. The firm maintains offices across the United States and Europe.
Blue Matter works to help pharmaceutical and biotechnology companies "maximize value at the product, portfolio, and company levels." The firm's services can be grouped into the following categories: New Product Planning, Launch Strategy and Management, Commercial Strategy for In-Line Products, and Organizational Design and Development.
While most of Blue Matter’s work involves pre-launch and launch products, the firm does not exclusively focus there. It works across a range of therapeutic areas but has developed specialized capabilities in oncology and rare diseases.